Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04595188
Other study ID # 1000071600
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 10, 2020
Est. completion date December 31, 2022

Study information

Verified date September 2023
Source The Hospital for Sick Children
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to determine the requirements for the sulphur amino acids in adults over the age of 60 years: 1. the total sulphur amino acid requirement as methionine only. Methionine is an essential amino acid. 2. the minimum methionine requirement as methionine in the presence of excess dietary cysteine. It is known that protein and amino acid metabolism may be altered with age and methionine and cysteine, in particular, may be important in the diet of older adults. Up to 7 different levels of methionine intake as methionine only (no dietary cysteine) and up to 7 different levels of methionine intake in the presence of excess dietary cysteine will be tested in each subject in random order. Each level of intake will involve a 3-day maintenance diet, with measures being collected on the third.


Description:

The sulphur amino acids (SAA) are methionine and cysteine. Methionine is essential and must be obtained from the diet whereas cysteine is considered non-essential and is synthesized from methionine. They have many other important roles that are secondary to their role in protein building. For example, they are needed to make the antioxidant glutathione (GSH), which protects the body's cells from damage. However, protein and GSH metabolism have been shown to change with age and hence, the SAA requirements may also be changed. Despite this, current SAA requirements are based on studies conducted in young adults. Thus, there is a need to determine the SAA requirements directly in older adults. The purpose of the study is to apply the minimally invasive indicator amino acid oxidation (IAAO) protocol to determine the SAA requirements in healthy adults over 60 years of age. The requirements will be determined as (1) the total sulphur amino acid requirement as methionine only and (2) the minimum methionine requirement by providing methionine in the presence of excess dietary cysteine. A pre-study assessment will be conducted to assess health status using: medical history and a physical exam; and a blood draw (10mL) for fasting blood glucose and hemoglobin A1c to test for diabetes, vitamin B and folate concentrations, and urea and creatinine to test renal function. In order to determine the requirements, each participant will be studied at up to 7 varying intakes levels of methionine in random order. Each intake level will be studied over 3-days: two adaptation days (day 1 and 2) and one study day (day 3). On the adaptation days, participants will be provided with a milkshake diet providing all the protein and nutrients they need. Participants will consume 4 meals/day in their usual home environment. On the 3rd day participants will come to the Clinical Research Centre at SickKids where they will be given hourly meals and breath and urine samples at specified times.A blood sample will also be collected for analysis of serum insulin, glucose and secondary parameters (i.e. concentrations of amino acids, glutathione, homocysteine and CRP). The mean (estimate average requirement) total sulphur amino acid requirement and minimum methionine requirement will be calculated with breakpoint analysis using a two-phase linear regression crossover analysis.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 90 Years
Eligibility Inclusion Criteria: - Consent provided - Aged 60 to 90 years old - In good general health as evidenced by medical history, physical health and blood draw - Fasting blood glucose, hemoglobin A1c (HbA1c), urea, creatinine, vitamin-B6, vitamin- B12 and folate levels within normal ranges for age. - Willingness to participate in the study. - BMI <30 kg/m2. Exclusion Criteria: - Presence of chronic disease and/or acute illness known to affect protein/amino acid metabolism (e.g. HIV, diabetes, cancer, liver or kidney disease, acute cold or flu) - Taking medications known to affect protein/AA metabolism (e.g. steroids) - Inability to tolerate the diet (i.e. allergy) - Significant weight loss during the past month or consumption of weight reducing diets. - Significant caffeine consumption (>2 cups per day) - Significant consumption of alcohol (>1 drink per day i.e. 1 beer or ½ glass of wine). - Unwilling to have blood drawn from a venous access, or using a ventilated hood indirect calorimeter for the purposes of the study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Sulphur amino acids
For the total sulphur amino acid requirement, there are 7 different methionine test levels (without dietary cysteine) ranging from 5 to 40 mg of methionine per kilogram body weight per day. For the minimum methionine requirement, there are 7 different methionine test levels (with excess dietary cysteine).

Locations

Country Name City State
Canada The Hospital for Sick Children Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
The Hospital for Sick Children Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determination of total sulphur amino acid requirements in adults >60 years of age methionine requirement the presence of zero cysteine up to 24 months
Secondary Determination of minimum sulphur amino acid requirements in adults >60 years of age methionine requirement in the presence of excess cysteine up to 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1